Sotera Health Co. (SHC)
18.50
+0.10
(+0.57%)
USD |
NASDAQ |
Oct 27, 16:00
18.50
0.00 (0.00%)
After-Hours: 19:12
Sotera Health Enterprise Value : 7.159B for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 7.159B |
| October 23, 2026 | 7.076B |
| October 22, 2026 | 7.085B |
| October 21, 2026 | 6.982B |
| October 20, 2026 | 7.028B |
| October 19, 2026 | 6.945B |
| October 16, 2026 | 7.016B |
| October 15, 2026 | 7.068B |
| October 14, 2026 | 6.971B |
| October 13, 2026 | 7.108B |
| October 12, 2026 | 7.091B |
| October 09, 2026 | 7.065B |
| October 08, 2026 | 6.999B |
| October 07, 2026 | 7.019B |
| October 06, 2026 | 7.119B |
| October 05, 2026 | 7.205B |
| October 02, 2026 | 7.111B |
| October 01, 2026 | 7.082B |
| September 30, 2026 | 7.188B |
| September 29, 2026 | 7.219B |
| September 28, 2026 | 7.176B |
| September 25, 2026 | 7.145B |
| September 24, 2026 | 7.176B |
| September 23, 2026 | 7.131B |
| September 22, 2026 | 7.245B |
| Date | Value |
|---|---|
| September 21, 2026 | 7.248B |
| September 18, 2026 | 7.256B |
| September 17, 2026 | 7.319B |
| September 16, 2026 | 7.427B |
| September 15, 2026 | 7.328B |
| September 14, 2026 | 7.196B |
| September 11, 2026 | 7.153B |
| September 10, 2026 | 7.122B |
| September 09, 2026 | 7.142B |
| September 08, 2026 | 7.216B |
| September 04, 2026 | 7.305B |
| September 03, 2026 | 7.342B |
| September 02, 2026 | 7.322B |
| September 01, 2026 | 7.242B |
| August 31, 2026 | 7.305B |
| August 28, 2026 | 7.410B |
| August 27, 2026 | 7.470B |
| August 26, 2026 | 7.487B |
| August 25, 2026 | 7.479B |
| August 24, 2026 | 7.382B |
| August 21, 2026 | 7.496B |
| August 20, 2026 | 7.396B |
| August 19, 2026 | 7.333B |
| August 18, 2026 | 7.193B |
| August 17, 2026 | 7.276B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ginkgo Bioworks Holdings, Inc. | 707.36M |
| Myriad Genetics, Inc. | 670.81M |
| Quest Diagnostics, Inc. | 32.61B |
| Labcorp Holdings, Inc. | 33.33B |
| OPKO Health, Inc. | 1.313B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 53.64M |
| Revenue (Quarterly) | 321.38M |
| Total Expenses (Quarterly) | 267.73M |
| EPS Diluted (Quarterly) | 0.1862 |
| Gross Profit Margin (Quarterly) | 54.44% |
| Profit Margin (Quarterly) | 16.69% |
| Earnings Yield | 3.07% |
| Operating Earnings Yield | 8.44% |
| Normalized Earnings Yield | 3.789 |